Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule
NCT05693116 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-01-20
Summary
The goal of this observational study is to learn about survival and prognostic factors in patients who underwent surgical treatment for primary squamous cell carcinoma of the nasal vestibule. The main questions it aims to answer are:
* what is the prognosis of patients affected by squamous cell carcinoma of the nasal vestibule?
* are there any specific factors that could influence prognosis?
* is it possible to elaborate a new staging system, able to overcome the limitations of the currently used ones? Data about patients, tumour and type of surgery performed will be collected. Participants will be followed-up for a minimum 6 months period after surgery.
Conditions
- Nasal Vestibule Carcinoma
- Rhinectomy
- Nasal Vestibule
- Squamous Cell Carcinoma
Interventions
- PROCEDURE
-
Rhinectomy
Surgery will be performed according to extension of the tumour, i.e. local resection limited to the vestibule, partial rhinectomy, total rhinectomy, extended total rhinectomy
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Principal Investigators
-
Fabio Ferreli, MD · Humanitas Research Hospital IRCCS, Rozzano-Milan
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2027-12-31
- Completion
- 2029-12-31
Countries
- France
- Italy
- United Kingdom
Study Locations
More Related Trials
-
Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
NCT02199132 ·Status: COMPLETED
-
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
NCT02099175 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Study of Sinonasal and Skull-base Tumours Management
NCT05607888 ·Status: RECRUITING
-
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833 ·Status: COMPLETED
-
HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors
NCT04979000 ·Status: COMPLETED
-
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
NCT02916368 ·Status: UNKNOWN
-
Real-World Evidence and Treatment Patterns: Head and Neck Cancer
NCT03157674 ·Status: COMPLETED
-
Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion
NCT05645783 ·Status: RECRUITING
-
A Study of Nivolumab in Patients With Head and Neck Cancer.
NCT04050761 ·Status: COMPLETED
-
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
NCT05483374 ·Status: RECRUITING
-
Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC
NCT05459415 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)
NCT05068609 ·Status: COMPLETED
-
Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC
NCT04681469 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning
NCT04151134 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
NCT03837613 ·Status: UNKNOWN
-
Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma
NCT05650034 ·Status: UNKNOWN ·Phase: NA
-
Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 ·Status: RECRUITING
-
A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy
NCT00116909 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
NCT06905145 ·Status: RECRUITING
-
Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer
NCT02817113 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma
NCT04146181 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
NCT07063212 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
NCT05909904 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Ribociclib and Spartalizumab in R/M HNSCC
NCT04213404 ·Status: UNKNOWN ·Phase: PHASE1
-
Human Papillomavirus and Oropharynx Carcinoma
NCT00918710 ·Status: UNKNOWN